Cargando…

Trends in endocrine therapy prescription and survival in patients with non-metastatic hormone receptor positive breast cancer treated with endocrine therapy: A population based-study

PURPOSE: To identify prognostic factors of invasive–disease free survival (iDFS) in women with non-metastatic hormone receptor positive (HR+) breast cancer (BC) in daily routine practice. METHODS: We performed a retrospective study using data from the Côte d’Or breast and gynecological cancer regist...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mamguem Kamga, Ariane, Billa, Oumar, Ladoire, Sylvain, Poillot, Marie-Laure, Jolimoy, Geneviève, Roignot, Patrick, Coutant, Charles, Desmoulins, Isabelle, Maynadie, Marc, Dabakuyo-Yonli, Tienhan Sandrine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8242053/ https://www.ncbi.nlm.nih.gov/pubmed/34174766 http://dx.doi.org/10.1016/j.breast.2021.06.003

Ejemplares similares

Survival in patients with HR+/HER2− metastatic breast cancer treated with initial endocrine therapy versus initial chemotherapy. A French population-based study
por: Simon, Julien, et al.
Publicado: (2020)

Impact of routine assessment of health-related quality of life coupled with therapeutic information on compliance with endocrine therapy in patients with non-metastatic breast cancer: protocol for a randomized controlled trial
por: Mamguem Kamga, Ariane, et al.
Publicado: (2020)

What Are Young Women Living Conditions after Breast Cancer? Health-Related Quality of Life, Sexual and Fertility Issues, Professional Reinsertion
por: Assogba, Emerline L. F., et al.
Publicado: (2020)

Impact of Covid-19 on breast cancer stage at discovery, and time to treatment in Cote d’Or, France
por: Feron Agbo, Clémence, et al.
Publicado: (2023)

Long-term quality of life and sexual function of elderly people with endometrial or ovarian cancer
por: Mamguem Kamga, Ariane, et al.
Publicado: (2021)

Breast cancer subtype of French women is not influenced by socioeconomic status: A population-based-study
por: Auguste, Aviane, et al.
Publicado: (2017)

Cross-sectional nationwide mixed-methods population-based study of living conditions, and identification of sexual and fertility profiles among young women after breast cancer in France: the Candy study protocol
por: Assogba, Emerline L F, et al.
Publicado: (2022)

Prognosis of local invasive relapses after carcinoma in situ of the breast: a retrospective study from a population-based registry
por: Kada Mohammed, Samia, et al.
Publicado: (2022)

Population-based study of breast cancer in older women: prognostic factors of relative survival and predictors of treatment
por: Dialla, Pegdwende Olivia, et al.
Publicado: (2012)

COVID-19 epidemiological, sociological and anthropological investigation: study protocol for a multidisciplinary mixed methods research in Burkina Faso
por: Traoré, Isidore Tiandiogo, et al.
Publicado: (2021)

Population-based study of ovarian cancer in Côte d'Or: prognostic factors and trends in relative survival rates over the last 20 years
por: Hamidou, Zeinab, et al.
Publicado: (2010)

Quality of life and perceived burden of the primary caregiver of patients aged 70 and over with cancer 5 years after initial treatment
por: Barben, Jérémy, et al.
Publicado: (2023)

For patients with breast cancer, geographic and social disparities are independent determinants of access to specialized surgeons. A eleven-year population-based multilevel analysis
por: Gentil, Julie, et al.
Publicado: (2012)

PB2697: LONG TERM PEJORATIVE IMPACT OF LENALIDOMIDE MAINTENANCE ON HEALTH-RELATED QUALITY OF LIFE IN CHRONIC LYMPHOCYTIC LEUKEMIA. ANCILLARY STUDY OF THE PHASE III CLL6-RESIDUUM TRIAL
por: Wasse, Stephane, et al.
Publicado: (2023)

Incidence rate and predictors of COVID-19 in the two largest cities of Burkina Faso - prospective cohort study in 2021 (ANRS-COV13)
por: Kaboré, Nongodo Firmin, et al.
Publicado: (2023)

The burden of the coronavirus disease 2019 virus infection in Burkina Faso: Results from a World Health Organization UNITY population‐based, age‐stratified sero‐epidemiological investigation
por: Ouedraogo, Samiratou, et al.
Publicado: (2023)

Impact of therapeutic strategy on disease‐free and overall survival of early‐stage cervical cancer: Surgery alone versus preoperative radiation
por: Mahiou, Katia, et al.
Publicado: (2023)

P1746: LONG-TERM NON-HODGKIN LYMPHOMA SURVIVORS IN CÔTE D’OR: HEALTH-RELATED QUALITY OF LIFE AND LIVING CONDITIONS.
por: Wasse, S., et al.
Publicado: (2022)

Randomized Trial Assessing the Impact of Routine Assessment of Health-Related Quality of Life in Patients with Head and Neck Cancer
por: Billa, Oumar, et al.
Publicado: (2021)

Impact de COVID-19 sur le stade du cancer du sein à la découverte et le délai de traitement en Côte d'Or, France
por: Feron Agbo, C., et al.
Publicado: (2023)

Factors Affecting Health-Related Quality of Life among Survivors of Non-Hodgkin Lymphoma: A Population-Based Study
por: Wasse, Stephane Kroudia, et al.
Publicado: (2023)

Effect of Obesity among Hospitalized Cancer Patients with or without COVID-19 on a National Level
por: Cottenet, Jonathan, et al.
Publicado: (2022)

Yoga: An endocrine therapy
por: Kaduskar, Prashant, et al.
Publicado: (2015)

Discussion on Endocrine Therapy
Publicado: (1926)

Enrolling study personnel in Ebola vaccine trials: from guidelines to practice in a non-epidemic context
por: Lhomme, Edouard, et al.
Publicado: (2019)

Drug Prescription Patterns and Cost Analysis of Diabetes Therapy in India: Audit of an Endocrine Practice
por: Singla, Rajiv, et al.
Publicado: (2019)

Improved adjuvant endocrine therapy for premenopausal women with endocrine responsive disease
por: Goldhirsch, Aron, et al.
Publicado: (2015)

Pre-operative Endocrine Therapy
por: Arthur, Laura M., et al.
Publicado: (2017)

Endocrine Toxicities of Antineoplastic Therapy
por: Puliani, Giulia, et al.
Publicado: (2021)

Current and future choices in endocrine therapy
por: Ellis, Matthew
Publicado: (2007)

Integration of endocrine therapy with targeted agents
por: Johnston, Stephen RD
Publicado: (2008)

Pharmacogenomics of endocrine therapy in breast cancer
por: Ingle, James N
Publicado: (2013)

Editorial: Resistance to Endocrine Therapies in Cancer
por: Ranganathan, Prathibha, et al.
Publicado: (2020)

Association of Endocrine Therapy for HR+/ERBB2+ Metastatic Breast Cancer With Survival Outcomes
por: Carausu, Marcela, et al.
Publicado: (2022)

SOCIETY FOR ENDOCRINOLOGY ENDOCRINE EMERGENCY GUIDANCE: Acute management of the endocrine complications of checkpoint inhibitor therapy
por: Higham, C E, et al.
Publicado: (2018)

Endocrine Follow-Up of Men with Non-Obstructive Azoospermia Following Testicular Sperm Extraction
por: Billa, Evangelia, et al.
Publicado: (2021)

Status of adjuvant endocrine therapy for breast cancer
por: Schiavon, Gaia, et al.
Publicado: (2014)

Endocrine therapy: defining the path of least resistance
por: Stone, Andrew, et al.
Publicado: (2014)

Pathways to Endocrine Therapy Resistance in Breast Cancer
por: Haque, Md. Moquitul, et al.
Publicado: (2019)

The immunomodulatory effects of endocrine therapy in breast cancer
por: Huang, Huanhuan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_sos43imvte4pqii2u51hhrraeg